A rare case of carbimazole induced severe aplastic anemia with fatal outcome

  • Authors

    • Naveen L MD Medicine, Assistant Professor in Medicine, Sri Devaraj Urs Medical College
    • Santoshi Malkarnekar MD Medicine, Assistant Professor in Medicine, Sri Devaraj Urs Medical College
    • Prathima S MD Pathology, Assistant Professor in Pathology, Sri Devaraj Urs Medical College
    2013-11-30
    https://doi.org/10.14419/ijpt.v2i1.1449

  • Abstract

    Though agranulocytosis is a well known adverse effect of antithyroid drugs ( ATDs), aplastic anemia is thought to be rare. Herein we present a case report of carbimazole induced aplastic anemia in a patient of Grave’s disease, who satisfied all the criteria for severe disease and had profound bone marrow hypoplasia. Drug induced aplastic anemia is thought to be a result of an idiosyncratic response directed against hematopoietic stem cells and is managed in a similar fashion to idiopathic aplastic anemia. The hematopoietic  damage in our patient did not recover following ATD withdrawal and supportive treatment. This necessitated the use of immunsuppressive therapy with cyclosporine and antitymocyte globulin, which she could not afford and despite of all the supportive treatment she eventually succumbed to severe sepsis. Since ATDs are commonly used in clinical practice, the physicians should be aware of this rare but life-threatening complication.

  • References

    1. Aydin Y, Berker D, Ustun I, Balcik O, Balli DN, Delibasi T, Peksoy I & Guler S (2008), A very rare case of aplastic anemia: Grave’s Disease. Southern Medical Journal 101, 666-667.
    2. Biswas N, Ahn YH, Goldman JM & Schwartz JM (1991), Aplastic anemia associated with antithyroid drugs. American Journal of Medical Sciences 301, 190-194.
    3. Escobar-Morreale HF, Bravo P, Garcia-Robles R, Garcia-Laran~a J, de la Calle H & Sancho JM (1997), Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony stimulating factor. Thyroid 7, 67-70.
    4. Kumar M & Goldman J (2002), Severe aplastic anemia and Grave’s disease in a paediatric patient. British Journal of Haematology 118, 327.
    5. Richardson JS, Sarkany I & Campbell CD (1954), Fatal case of marrow aplasia after treatment with carbimazole. British Medical Journal 1, 364-365.
    6. The International Agranulocytosis and Aplastic Anemia Study (1987), Incidence of aplastic anemia: the relevant diagnostic criteria. Blood 70, 1718.
    7. Williams DM (1999), Pancytopenia, aplastic anemia and pure red cell aplasia (GR Lee, J Foerster, J Lukens, et al. ed), Williams & Wilkins, Baltimore, pp. 1186-1187.
    8. Young NS, Calado RT & Scheinberg P (2006), Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108, 250.

  • Downloads

  • How to Cite

    L, N., Malkarnekar, S., & S, P. (2013). A rare case of carbimazole induced severe aplastic anemia with fatal outcome. International Journal of Pharmacology and Toxicology, 2(1), 1-2. https://doi.org/10.14419/ijpt.v2i1.1449

    Received date: 2013-10-25

    Accepted date: 2013-11-17

    Published date: 2013-11-30